Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

47759

	registered interest
	date	08/04/2014
	answering body	Scotland Office
	answering dept id	2
	answering dept short name	Scotland
	answering dept sort name	Scotland
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what is the percentage cost over-run established by the management board for any budget in the Scotland Office to merit being tabled at the departmental management board; and how many times in the last 12 months that has occurred.
	tabling member printed	Lord Mendelsohn
	uin	HL6707
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p> </p><p>The Scotland Office does not have a cost overrun established by its management board above which it merits a budget being tabled at its management board. No overruns have been reported to the management board in the last 12 months.</p><p> </p> answering member printed Lord Wallace of Tankerness question first answered 08/05/2014 12:00:00 answering member 630 label Biography information for Lord Wallace of Tankerness
	tabling member	4286 label Biography information for Lord Mendelsohn

47831

	registered interest
	date	09/04/2014
	answering body	Department for Culture Media and Sport
	answering dept id	10
	answering dept short name	Culture, Media and Sport
	answering dept sort name	Culture, Media and Sport
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, in the light of the BBC's decision to withdraw one of its black and minority ethnic (BME) reporter posts and its BBC UK Black weekly Podcast, whether in the negotiations with the BBC in respect of the renewal of its Charter they intend to set requirements relating to the coverage of BME issues in the BBC's output; and if so, what requirements.
	tabling member printed	Lord Patel of Bradford
	uin	HL6773
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The process, scope and timing of the review of the BBC's Charter has yet to be determined. However, the Government is committed to the issue of BAME diversity in TV, film and the Arts, both on and off screen. The Culture Minister recently met with leading figures from these sectors, including the BBC, to consider options to improve representation.</p> answering member printed Lord Gardiner of Kimble question first answered 08/05/2014 12:00:00 answering member 4161 label Biography information for Lord Gardiner of Kimble
	tabling member	3798 label Biography information for Lord Patel of Bradford

49510

	registered interest
	date	01/05/2014
	answering body	Ministry of Justice
	answering dept id	54
	answering dept short name	Justice
	answering dept sort name	Justice
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Justice, how many police cautions were issued in Brigg and Goole constituency in each of the last five years.
	tabling member constituency	Brigg and Goole
	tabling member printed	Andrew Percy
	uin	197598
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p /> <p>Information on cautions is not held by parliamentary constituency</p> answering member constituency Ashford answering member printed Damian Green question first answered 08/05/2014 12:00:00 answering member 76 label Biography information for Damian Green
	tabling member	3939 label Biography information for Andrew Percy

49414

	registered interest
	date	01/05/2014
	answering body	Foreign and Commonwealth Office
	answering dept id	16
	answering dept short name	Foreign and Commonwealth Office
	answering dept sort name	Foreign and Commonwealth Office
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, when he intends to reply to the letter to him dated 25 March 2014 from the right hon. Member for Manchester, Gorton with regard to Mr M Woronycz.
	tabling member constituency	Manchester, Gorton
	tabling member printed	Sir Gerald Kaufman
	uin	197503
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The Secretary of State for Foreign and Commonwealth Affairs, my right hon. Friend the Member for Richmond (Yorks) (Mr Hague) responded to the right hon. Member on 1 May 2014.</p> answering member constituency Aylesbury answering member printed Mr David Lidington question first answered 08/05/2014 12:00:00 answering member 15 label Biography information for Sir David Lidington
	tabling member	451 label Biography information for Sir Gerald Kaufman

49236

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what progress NHS England is making on improving access to stereotactic ablative radiotherapy for patients suffering with cancer of the prostate, liver, pancreas, spinal tumours and cancer of the head and neck.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197267
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The business case for the gamma-knife centre at Oxford was originally agreed with the primary care trust (PCT) prior to April 2013, with an assumption that the PCT would stop sending patients to other centres elsewhere, and start sending them to the new centre once it was completed.</p><p> </p><p>As of April 2013, commissioning of these services transferred to the specialist commissioning team in NHS England.</p><p> </p><p>NHS England is currently undertaking a review of stereotactic radiosurgery (SRS) (e.g. Gamma Knife) and stereotactic ablative radiotherapy (SABR, e.g. Cyber-knife) for intracranial conditions to establish what the national demand is in line with its national clinical commissioning policies on SRS and SABR, and what the national capacity requirements are for this specialised treatment.</p><p> </p><p>Until the capacity requirements are clear, NHS England has said that it would be inappropriate to encourage new market entrants to provide this service as it cannot be clear what the potential consequential impacts on service quality, sustainability (financial and clinical) and potential unintended changes to patient pathways will be. Until the review is complete NHS England has said no substantive changes will be made to the current provision.</p><p> </p><p>As part of the transition of this service to NHS England, it developed, consulted upon and published a series of national clinical commissioning policies for intracranial SRS and SRT treatment.</p><p> </p><p>A report setting out the emerging findings of this review has been shared with clinical reference groups to seek their views and help NHS England develop a final draft. Once the views of stakeholders have been gathered, this will then go to Specialised Commissioning Oversight Group (SCOG) to agree a preferred option. Once the SCOG has a preferred option, NHS England will consult with patients and professionals and take account of those views when taking a final decision. If it is concluded there are to be significant changes in the provision of services, there will be a full public consultation before any changes are made.</p><p> </p><p>NHS England is expecting that the draft report will be ready for consideration at SCOG in June and then it would commence a public consultation on the draft report and preferred option during July to September. The report and recommendations will then be finalised after taking account of the views expressed during the consultation stage and a final decision taken by SCOG in September 2014.</p><p> </p><p>NHS England inherited the range of gamma knife providers currently in place, of which University College London Hospitals (UCLH) was not one. NHS England is currently undertaking a review of stereotactic radiosurgery provision and will consult widely with stakeholders and providers prior to making changes to service provision. There are two long established providers of gamma knife surgery commissioned by NHS England located in central London to whom patients from all six London specialist neurosurgical centres have been referred for gamma knife treatment for a number of years, including patients from UCLH.</p><p> </p><p>Finally, there was no contract in place with UCLH to provide gamma knife surgery for any PCT prior to 1 April 2013. Any activity that may have been undertaken there would have been done on an ad-hoc, non-contracted basis and NHS England does not hold this information.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197268 197298 197299 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

49237

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will take steps to encourage NHS England to respond to the Oxford Radiosurgery Centre's request that NHS patients in Oxfordshire and surrounding counties who require radiosurgery be treated there.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197268
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The business case for the gamma-knife centre at Oxford was originally agreed with the primary care trust (PCT) prior to April 2013, with an assumption that the PCT would stop sending patients to other centres elsewhere, and start sending them to the new centre once it was completed.</p><p> </p><p>As of April 2013, commissioning of these services transferred to the specialist commissioning team in NHS England.</p><p> </p><p>NHS England is currently undertaking a review of stereotactic radiosurgery (SRS) (e.g. Gamma Knife) and stereotactic ablative radiotherapy (SABR, e.g. Cyber-knife) for intracranial conditions to establish what the national demand is in line with its national clinical commissioning policies on SRS and SABR, and what the national capacity requirements are for this specialised treatment.</p><p> </p><p>Until the capacity requirements are clear, NHS England has said that it would be inappropriate to encourage new market entrants to provide this service as it cannot be clear what the potential consequential impacts on service quality, sustainability (financial and clinical) and potential unintended changes to patient pathways will be. Until the review is complete NHS England has said no substantive changes will be made to the current provision.</p><p> </p><p>As part of the transition of this service to NHS England, it developed, consulted upon and published a series of national clinical commissioning policies for intracranial SRS and SRT treatment.</p><p> </p><p>A report setting out the emerging findings of this review has been shared with clinical reference groups to seek their views and help NHS England develop a final draft. Once the views of stakeholders have been gathered, this will then go to Specialised Commissioning Oversight Group (SCOG) to agree a preferred option. Once the SCOG has a preferred option, NHS England will consult with patients and professionals and take account of those views when taking a final decision. If it is concluded there are to be significant changes in the provision of services, there will be a full public consultation before any changes are made.</p><p> </p><p>NHS England is expecting that the draft report will be ready for consideration at SCOG in June and then it would commence a public consultation on the draft report and preferred option during July to September. The report and recommendations will then be finalised after taking account of the views expressed during the consultation stage and a final decision taken by SCOG in September 2014.</p><p> </p><p>NHS England inherited the range of gamma knife providers currently in place, of which University College London Hospitals (UCLH) was not one. NHS England is currently undertaking a review of stereotactic radiosurgery provision and will consult widely with stakeholders and providers prior to making changes to service provision. There are two long established providers of gamma knife surgery commissioned by NHS England located in central London to whom patients from all six London specialist neurosurgical centres have been referred for gamma knife treatment for a number of years, including patients from UCLH.</p><p> </p><p>Finally, there was no contract in place with UCLH to provide gamma knife surgery for any PCT prior to 1 April 2013. Any activity that may have been undertaken there would have been done on an ad-hoc, non-contracted basis and NHS England does not hold this information.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197267 197298 197299 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

49238

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many patients have been sent to hospitals in London for stereotactic radiosurgery treatment from (a) Oxfordshire, (b) Berkshire, (c) Buckinghamshire and (d) Wiltshire in each of the last three financial years.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197271
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The requested information is not collected centrally.</p><p> </p><p>We understand Mr James Palmer, Clinical Director of Specialised Services at NHS England will be writing to my hon. Friend to offer a meeting in order that he can address concerns about the provision of stereotactic radiosurgery treatment.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197263 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

49239

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many patients have been sent to hospitals in Sheffield for stereotactic radiosurgery treatment from (a) Oxfordshire, (b) Berkshire, (c) Buckinghamshire and (d) Wiltshire in each of the last three financial years.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197263
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The requested information is not collected centrally.</p><p> </p><p>We understand Mr James Palmer, Clinical Director of Specialised Services at NHS England will be writing to my hon. Friend to offer a meeting in order that he can address concerns about the provision of stereotactic radiosurgery treatment.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197271 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

49240

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 24 March 2014, Official Report, column 132W, on radiotherapy and with reference to section three of the guidance issued by Monitor on the Commissioning of Radiosurgery Services on 4 April 2014, which primary care trusts in the south west of England commissioned treatment with the Gamma Knife at University College London Hospital for patients before 1 April 2013.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197298
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The business case for the gamma-knife centre at Oxford was originally agreed with the primary care trust (PCT) prior to April 2013, with an assumption that the PCT would stop sending patients to other centres elsewhere, and start sending them to the new centre once it was completed.</p><p> </p><p>As of April 2013, commissioning of these services transferred to the specialist commissioning team in NHS England.</p><p> </p><p>NHS England is currently undertaking a review of stereotactic radiosurgery (SRS) (e.g. Gamma Knife) and stereotactic ablative radiotherapy (SABR, e.g. Cyber-knife) for intracranial conditions to establish what the national demand is in line with its national clinical commissioning policies on SRS and SABR, and what the national capacity requirements are for this specialised treatment.</p><p> </p><p>Until the capacity requirements are clear, NHS England has said that it would be inappropriate to encourage new market entrants to provide this service as it cannot be clear what the potential consequential impacts on service quality, sustainability (financial and clinical) and potential unintended changes to patient pathways will be. Until the review is complete NHS England has said no substantive changes will be made to the current provision.</p><p> </p><p>As part of the transition of this service to NHS England, it developed, consulted upon and published a series of national clinical commissioning policies for intracranial SRS and SRT treatment.</p><p> </p><p>A report setting out the emerging findings of this review has been shared with clinical reference groups to seek their views and help NHS England develop a final draft. Once the views of stakeholders have been gathered, this will then go to Specialised Commissioning Oversight Group (SCOG) to agree a preferred option. Once the SCOG has a preferred option, NHS England will consult with patients and professionals and take account of those views when taking a final decision. If it is concluded there are to be significant changes in the provision of services, there will be a full public consultation before any changes are made.</p><p> </p><p>NHS England is expecting that the draft report will be ready for consideration at SCOG in June and then it would commence a public consultation on the draft report and preferred option during July to September. The report and recommendations will then be finalised after taking account of the views expressed during the consultation stage and a final decision taken by SCOG in September 2014.</p><p> </p><p>NHS England inherited the range of gamma knife providers currently in place, of which University College London Hospitals (UCLH) was not one. NHS England is currently undertaking a review of stereotactic radiosurgery provision and will consult widely with stakeholders and providers prior to making changes to service provision. There are two long established providers of gamma knife surgery commissioned by NHS England located in central London to whom patients from all six London specialist neurosurgical centres have been referred for gamma knife treatment for a number of years, including patients from UCLH.</p><p> </p><p>Finally, there was no contract in place with UCLH to provide gamma knife surgery for any PCT prior to 1 April 2013. Any activity that may have been undertaken there would have been done on an ad-hoc, non-contracted basis and NHS England does not hold this information.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197267 197268 197299 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

49241

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 24 March 2014, Official Report, column 132W, on radiotherapy and with reference to section three of the guidance issued by Monitor on the Commissioning of Radiosurgery Services on 4 April 2014, for what reasons NHS England is not funding patients to be treated with the Gamma Knife at University College London Hospital.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197299
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The business case for the gamma-knife centre at Oxford was originally agreed with the primary care trust (PCT) prior to April 2013, with an assumption that the PCT would stop sending patients to other centres elsewhere, and start sending them to the new centre once it was completed.</p><p> </p><p>As of April 2013, commissioning of these services transferred to the specialist commissioning team in NHS England.</p><p> </p><p>NHS England is currently undertaking a review of stereotactic radiosurgery (SRS) (e.g. Gamma Knife) and stereotactic ablative radiotherapy (SABR, e.g. Cyber-knife) for intracranial conditions to establish what the national demand is in line with its national clinical commissioning policies on SRS and SABR, and what the national capacity requirements are for this specialised treatment.</p><p> </p><p>Until the capacity requirements are clear, NHS England has said that it would be inappropriate to encourage new market entrants to provide this service as it cannot be clear what the potential consequential impacts on service quality, sustainability (financial and clinical) and potential unintended changes to patient pathways will be. Until the review is complete NHS England has said no substantive changes will be made to the current provision.</p><p> </p><p>As part of the transition of this service to NHS England, it developed, consulted upon and published a series of national clinical commissioning policies for intracranial SRS and SRT treatment.</p><p> </p><p>A report setting out the emerging findings of this review has been shared with clinical reference groups to seek their views and help NHS England develop a final draft. Once the views of stakeholders have been gathered, this will then go to Specialised Commissioning Oversight Group (SCOG) to agree a preferred option. Once the SCOG has a preferred option, NHS England will consult with patients and professionals and take account of those views when taking a final decision. If it is concluded there are to be significant changes in the provision of services, there will be a full public consultation before any changes are made.</p><p> </p><p>NHS England is expecting that the draft report will be ready for consideration at SCOG in June and then it would commence a public consultation on the draft report and preferred option during July to September. The report and recommendations will then be finalised after taking account of the views expressed during the consultation stage and a final decision taken by SCOG in September 2014.</p><p> </p><p>NHS England inherited the range of gamma knife providers currently in place, of which University College London Hospitals (UCLH) was not one. NHS England is currently undertaking a review of stereotactic radiosurgery provision and will consult widely with stakeholders and providers prior to making changes to service provision. There are two long established providers of gamma knife surgery commissioned by NHS England located in central London to whom patients from all six London specialist neurosurgical centres have been referred for gamma knife treatment for a number of years, including patients from UCLH.</p><p> </p><p>Finally, there was no contract in place with UCLH to provide gamma knife surgery for any PCT prior to 1 April 2013. Any activity that may have been undertaken there would have been done on an ad-hoc, non-contracted basis and NHS England does not hold this information.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197267 197268 197298 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt